Full Breakdown
Missouri Supreme Court Upholds Ban on Gender-Affirming Care for Minors
1/15/2026, 1:11:14 AM
Overview of the Ruling
On January 13, 2026, the Missouri Supreme Court unanimously upheld Senate Bill 49, also known as the Missouri Save Adolescents from Experimentation (SAFE) Act. This law prohibits gender transition surgeries, cross-sex hormones, and puberty blockers for minors, as well as banning Medicaid coverage for gender-affirming care for individuals of all ages. The court's decision affirms a previous ruling from the Cole County Circuit Court, which sided with the state on all counts.
Legal Context and Arguments
The SAFE Act, enacted in 2023, was challenged by the American Civil Liberties Union (ACLU) of Missouri, Lambda Legal, and several families of transgender youth. They argued that the law discriminates against transgender individuals, violating equal protection and due process clauses of the Missouri Constitution. However, Judge Kelly Broniec, writing for the court, stated that the law does not infringe on fundamental rights and is subject to rational-basis review, which presumes the law is sensible unless proven otherwise. The court concluded that the law classifies individuals based solely on age and medical use, aligning with recent U.S. Supreme Court decisions regarding similar bans in other states.
Implications of the Decision
The ruling allows Missouri to continue enforcing restrictions on gender-affirming care, which advocates argue are medically necessary for transgender youth. The court's decision has been met with strong opposition from LGBTQ+ advocacy groups, who contend that the law undermines parental rights and access to essential healthcare. The ACLU and Lambda Legal have indicated they may explore further legal avenues to challenge the ruling.
Official Statements
Missouri Attorney General Catherine Hanaway hailed the ruling as a significant victory for families, asserting that it protects children from "dangerous, untested, and experimental procedures." She emphasized the state's commitment to safeguarding the health and well-being of its youth. Conversely, Katy Erker-Lynch, executive director of PROMO Missouri, criticized the decision, stating, "This discriminatory law invades the private relationship between patients, their families, and their doctors, denying transgender people access to safe and effective medical care."
Criticism and Opposition
Critics of the ruling argue that it perpetuates discrimination against transgender individuals and undermines the autonomy of families to make medical decisions for their children. Medical associations, including the American Academy of Pediatrics, have previously condemned such restrictions, labeling them as baseless intrusions into the patient-physician relationship. The ACLU's Gillian Wilcox described the ruling as allowing Missouri to enforce a "harmful ban" that singles out transgender residents.
What's Next
The SAFE Act is set to expire in 2027, but lawmakers have expressed intentions to make the prohibitions permanent. Additionally, a ballot initiative planned for November aims to extend the ban indefinitely. Advocacy groups continue to mobilize resources for affected families, emphasizing the ongoing need for support amid the legal and social challenges posed by the ruling.
Verbatim Quotes
- “This win sends a clear message: Missouri will always protect children from dangerous, untested, and experimental procedures.” — Catherine Hanaway, Missouri Attorney General
- “Denying medically necessary healthcare to anyone is not only shameful, but irrefutably wicked.” — Katy Erker-Lynch, Executive Director of PROMO Missouri
- “The government’s actions today make that task harder, if not impossible, for families of gender-diverse and transgender youth,” — Susan J. Kressly, President of the American Academy of Pediatrics
This ruling marks a pivotal moment in the ongoing debate over transgender rights and healthcare access in Missouri, reflecting broader national trends and tensions surrounding these issues.
